Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.
Lucien Wiggins, 12, arrived at Tufts Children’s Hospital by ambulance June 7 with chest pain, dizziness and high protein levels in his blood shown. inflammation in his heart. The symptoms started one day early, the morning after his second vaccination of Pfizer-BioNTech shot mRNA.
For Dr. Sara Ross, head of critical child care at the Boston hospital, confirmed in the event the skepticism she was breastfeeding: Did the country push the luck of vaccination of children against COVID at a time when the disease is relatively mild in the child – and the skepticism of vaccines is frighteningly high?
“I’ve practiced in the pediatric ICU for almost 15 years and I’ve never cared for a patient with a vaccine-related complication to date,” Ross told Kaiser Health News. “Our standard for safety is as different as all the other vaccines we expose to children.”
To be sure, the cases of myocarditis as of Lucien which is rare, and the reported effects, although sometimes serious, are generally resolved with pain relievers and sometimes, infusion of antibodies. And an infection with COVID itself is the most likely cause of the vaccine myocarditis, including young people.
EXCLUSIVE SPEECH: A 21-year-old NJ student suffered severe heart inflammation after receiving a second dose of the Moderna COVID vaccine. Justin Harrington, whose school requires him to get the vaccine…
– Robert F. Kennedy Jr. (@RobertKennedyJr) June 15, 2021
Lucien returned home, recovering, after two days of intravenous ibuprofen with intensive care. Most of the 800 or more cases of heart problems among all ages were reported in a federal vaccine database as of May 31 following a similar course. Although the pattern in these cases – mostly occurs in young men after the second Pfizer or Modern shot – suggested disease cause of the vaccine, rather than coincidence.
At a time when the vaccination campaign has slowed, leading conservatives have apparently spread disinformation about vaccines, and scientists fear a possible outbreak of cases in the fall or winter, the effects on young people. provides difficulty for public health officials.
On Friday, June 18, it is intended that the vaccine advisory committee of the Centers for Disease Control and Prevention will meet to discuss the possible link and whether it is appropriate to update its recommendations for vaccinating adolescents with the vaccine. Pfizer, where the Food and Drug Administration last month authorized for children 12 and older. The same approval is awaited for the Moderna vaccine, and the same companies are conducting clinical trials to test their vaccines on children as young as 6 years of age.
At a meeting last week of an FDA advisory committee, vaccine experts suggested the agency should drug companies to sustain more numerous and longer clinical trials for younger age groups. Some say the FDA should stop allowing vaccination of young children for up to a year or two.
Interestingly, Lucien and his mother, Beth Clarke, of Rochester, New Hampshire, disagreed. Her son’s reaction was “strange,” she said, but “I’d rather he had an impact. [that doctors] help than get COVID and possibly die. And he felt that, which was even more important. He thinks all his friends should get it. “
Data on the effect of COVID on children are somewhat confusing, however 300 COVID -related deaths and thousands hospitalized reported in children under 18, making the COVID toll much or greater than any childhood disease for which a vaccine is currently available. The American Academy of Pediatrics wants children to receive the vaccine, thinking that tests show it is safe.
But healthy people under the age of 18 generally do not suffer major side effects of COVID, and the number of severe cases in young people has plummeted while many adults have been vaccinated. Unlike other pathogens, such as influenza, children are mostly uninfected elderly, frail adults.
Under these circumstances, Drs. Cody Meissner – who as head of infectious diseases in Tufts children consulted Lucien’s case – the benefits of the COVID vaccine at this point may not outweigh the risk for children.
“We all want a child vaccine, but I’m worried about the issue of safety,” Meissner told colleagues on the advisory commission last week. A Study of Israel found a five to 25-fold increase in heart disease among men aged 16-24 who vaccinated with Pfizer shot. Most recover within a few weeks. Two deaths occurred in vaccinated men unrelated to the vaccine.
Young people can experience long-term side effects from suspected vaccine side effects such as scarring, irregular heartbeat or even early heart failure, according to Meissner, so it makes sense to wait until it becomes the problem is more obvious.
“Could the disease return this fall? Sure. But the likelihood is that I think it’s pretty short. And our first mandate is to be harmless,” he said.
Ross said the most common pandemic threat to children witnessed in his ICU was drug overdoses and mental illness brought on by the closure of normal life.
“Young children are not vectors of disease, nor are they driving the spread of the epidemic,” Ross said. While later everyone should be vaccinated against COVID, the use of vaccines should not be extended to children who do not have much safety information, he said.
The government may allow childhood vaccination against COVID if it is not immediately recommended, Drs. Eric Rubin, a member of the advisory committee editor-in-chief of the New England Journal of Medicine. “In September, when kids are back in school, people are indoors, and vaccination rates are going down in some parts of the country, who knows what things will look like. “We may want this vaccine.”
Moderna and Pfizer this summer began testing their vaccines on young children. A Pfizer spokesman said the company expects to give 2,250 children ages 6 months-11 years the vaccine as part of its trial; Moderna said it will vaccinate about 3,500 children ages 2-11.
Some members of the FDA’s advisory committee suggest that up to 10,000 children be included in each trial. But Marion Gruber, head of the FDA’s vaccine regulation office, points out that even fewer trials can detect an effect as unique as myocarditis.
At some point, federal regulators and the public will have to decide how much risk they want to accept from vaccines against the risk of a COVID virus that continues to spread and change around the world, according to Dr. . Paul Offit, director of the Vaccine Education Center at Children’s Hospital in Philadelphia.
“We need the population to have been vaccinated for many years or maybe decades,” Offit said at the meeting. “It seems hard to imagine that we can’t vaccinate kids in the future.”
Ross argues it would be more reasonable to choose to vaccinate children most at risk for severe COVID disease, such as those who are obese or have diabetes. Even to raise questions about the vaccination program would be a freighted decision, he said. While the authorities have a duty to speak frankly about the safety of vaccines, they also have a responsibility not to intimidate the public in such a way that they cannot seek protection.
A 10 day stop Johnson and Johnson vaccination campaign in April, as authorities investigated a link to the sometimes deadly blood -borne disease, causing a significant reduction in public confidence of that vaccine, even if in late May the authorities only spotted 28 cases among the 8.7 million who received the U.S. vaccine. Due to the declining appetite of the Johnson & Johnson vaccine, millions of doses are at risk of passing their used date to refrigerators across the country.
Focusing too much attention on the potential harms from the Pfizer and Moderna vaccines for children could have a dire consequence, according to Drs. hesitation of the vaccine. “It’s easy for us to get into a situation where we need to vaccinate this population, but it’s too late because you’ve already given the message that we shouldn’t have done this,” he said.
Later, perhaps next year, K-12 orders could be called for, according to Drs. Sean O’Leary, a professor of infectious diseases in children at the University of Colorado. “There is a lot of misinformation and propaganda spreading that people are refusing to go there, to further insert the horn nest,” he said. But once there’s strong safety data for kids, “when you think about it, there’s no logical or ethical reason why you shouldn’t.”
Originally published on Kaiser Health News.
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children’s Health Defense.